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Opioid Substitution Treatment (OST) patterns 2009-2020 
(Prepared by the HSE National Social Inclusion Office) 
The Central Treatment List is a HSE register of people that receive 
treatment for problem opiate use. Methadone is the main form of OST 
treatment received, although buprenorphine (suboxone or subutex) 
treatment is also provided. During 2020, the HSE’s Drug and Alcohol 
services inducted a total of 721 new patients onto OST and 161 of those 
commenced on treatment during the year were registered as Homeless. 
Figures 1 and 2 show the number of people receiving methadone and 
buprenorphine treatment since 2009 respectively. It can be seen that 
methadone treatment has increased by 21% since 2009 and by 6% since 
2019, while buprenorphine treatment has increased by 254% since 2018, 
and 61% since 2019. Overall OST has increased by 25% since 2009 and 
7% since 2019 (figure 3). The Misuse of Drugs Regulations were amended 
in 2017 to allow for the use of buprenorphine containing products licensed 
for opioid substitution treatment to be made available as part of OST 
(Irish Statute Book, 2017). These regulations have made buprenorphine 
more accessible for treatment. In addition, at the start of the Covid 19 
pandemic the National Social Inclusion Office released clinical guidance on 
OST prescribing which encouraged the use of buprenorphine due to its 
easier induction process (National Social Inclusion Office, 2020). This may 
help explain the steep rise in its use during 2020.   
Figure 1:  Number treated with methadone for problem opiate use 
 
Source: Central Treatment List 
Figure 2:  Number treated with buprenorphine for problem opiate 
use 
 


















































































Figure 3:  Number treated with OST (methadone or 
buprenorphine) for problem opiate use 
 




National Social Inclusion Office (2020) Guidance on Contingency Planning 




Irish Statute Book (2017) S.I. No. 522/2017 - Misuse of Drugs 
(Supervision of Prescription and Supply of Methadone and Medicinal 
Products containing Buprenorphine authorised for Opioid Substitution 
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